What Led The Homology Medicines (FIXX) Stock To Increase After Hours?
Following the release of preliminary results from a clinical trial, Homology Medicines Inc. (NASD: FIXX) saw a 3.08% increase to $1.34 in after-hours trading on Wednesday. What information has FIXX offered? pheEDIT Phase 1 gene editing experiment with HMI-103 for phenylketonuria (PKU) and juMPStart Phase 1 gene therapy trial with HMI-203 for Hunter syndrome enrollment […]